- What is the optimal strategy of prehospital pretreatment of STEMI patients with P2Y12 inhibitors? Experience from Pilsner region in the years 2013-20142016 | Faculty of Medicine in Pilsen
- Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations2015 | Third Faculty of Medicine
- Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction2016 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- The relationship between symptom onset-to-needle time and ischemic outcomes in patients with acute myocardial infarction treated with primary PCI: Observations from Prague-18 Study2022 | Third Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Antiplatelet therapy - A pharmacologist's perspective2013 | Third Faculty of Medicine
- RE-DUAL PCI trial - percutaneous coronary intervention in patient with atrial fibrillation treated with dabigatran2018 | Publication without faculty affiliation
- Reply: Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the Trials2018 | Third Faculty of Medicine, Central Library of Charles University
- Editorial: The individualization of antiplatelet therapy in coronary artery disease: escalation or de-escalations2023 | Third Faculty of Medicine
- Antiplatelet effect of prasugrel and clopidogrel in hypothermic patients after cardiac arrest for acute myocardial infarction2014 | Third Faculty of Medicine, Faculty of Mathematics and Physics
- Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries2016 | Third Faculty of Medicine
- Antiplatelet therapy in patients after an acute coronary syndrome: Comparison of the Czech and Slovak Republics Results of the ATHRO registry2014 | Third Faculty of Medicine
- Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention Multicenter Randomized PRAGUE-18 Study2016 | Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- P2Y(12) inhibitor loading time before elective PCI and the prevention of myocardial necrosis2024 | Third Faculty of Medicine
- Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes2017 | Third Faculty of Medicine
- 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration2020 | Publication without faculty affiliation
- 1-Year Outcomes of Patients Undergoing Primary Angioplasty for Myocardial Infarction Treated With Prasugrel Versus Ticagrelor2018 | Third Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Impact of admitting department on the management of acute coronary syndrome after an out of hospital cardiac arrest2023 | Third Faculty of Medicine, Central Library of Charles University
- Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis2019 | Publication without faculty affiliation
- Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIXPublication without faculty affiliation
- Antithrombotic therapy and digestive endoscopy2022 | Faculty of Medicine in Hradec Králové